ID
16691
Beschrijving
Sponsor: OSI Pharmaceuticals Information provided by (Responsible Party): Astellas Pharma Inc ( OSI Pharmaceuticals ) A multicenter, randomized, double-blind, placebo-controlled, phase 3 study of single-agent Tarceva® (erlotinib) following complete tumor resection with or without adjuvant chemotherapy in patients with stage IB-IIIA non-small cell lung carcinoma who have EGFR-positive tumors. See https://clinicaltrials.gov/ct2/show/NCT00373425 Part of study: Screening Assessments
Link
https://clinicaltrials.gov/ct2/show/NCT00373425
Trefwoorden
Versies (2)
- 27-07-16 27-07-16 -
- 01-08-16 01-08-16 -
Geüploaded op
1 augustus 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Screening Assessments, Tarceva in NSCLC patients who have EGFR-positive tumors DRKS00001485 NCT00373425
Screening Assessments, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425
Beschrijving
Demographics
Beschrijving
Date of birth
Datatype
date
Alias
- UMLS CUI [1]
- C0421451
Beschrijving
Gender
Datatype
integer
Alias
- UMLS CUI [1]
- C0079399
Beschrijving
Ethnicity
Datatype
integer
Alias
- UMLS CUI [1]
- C0015031
Beschrijving
Race
Datatype
integer
Alias
- UMLS CUI [1]
- C0034510
Beschrijving
Race
Datatype
text
Alias
- UMLS CUI [1]
- C0034510
Beschrijving
Screening Eligibility Criteria
Beschrijving
Inclusion Criteria
Datatype
boolean
Alias
- UMLS CUI [1]
- C1512693
Beschrijving
Inclusion Criteria
Datatype
text
Alias
- UMLS CUI [1]
- C1512693
Beschrijving
Exclusion Criteria
Datatype
boolean
Alias
- UMLS CUI [1]
- C0680251
Beschrijving
Exclusion Criteria
Datatype
text
Alias
- UMLS CUI [1]
- C0680251
Beschrijving
Eligibility Criteria
Datatype
integer
Alias
- UMLS CUI [1,1]
- C1516637
- UMLS CUI [1,2]
- C2348482
Beschrijving
Date screening consent was signed
Datatype
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C0021430
Beschrijving
IVRS Screening Number
Datatype
text
Alias
- UMLS CUI [1]
- C1710477
Beschrijving
Treatment Eligibility Criteria
Beschrijving
Inclusion Criteria
Datatype
boolean
Alias
- UMLS CUI [1]
- C1512693
Beschrijving
Inclusion Criteria
Datatype
text
Alias
- UMLS CUI [1]
- C1512693
Beschrijving
Exclusion Criteria
Datatype
boolean
Alias
- UMLS CUI [1]
- C0680251
Beschrijving
Exclusion Criteria
Datatype
text
Alias
- UMLS CUI [1]
- C0680251
Beschrijving
Eligibility Criteria
Datatype
integer
Alias
- UMLS CUI [1,1]
- C1516637
- UMLS CUI [1,2]
- C2348482
Beschrijving
Date main study consent was signed
Datatype
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C0021430
Beschrijving
IVRS Randomization
Similar models
Screening Assessments, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425
C0600091 (UMLS CUI [1,2])
C2348482 (UMLS CUI [1,2])
C0021430 (UMLS CUI [1,2])
C2348482 (UMLS CUI [1,2])
C0021430 (UMLS CUI [1,2])
C0034656 (UMLS CUI [1,2])